EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lipid Peroxidation in Cancer Therapy: Molecular Mechanisms Involving Oxidative Stress, Cell Death, and Therapeutic Response

Wiktoria Andryszkiewicz iD, Zuzanna Cichowska, Michał Filipski iD, Kamila Szyda, Anna Wietrzyk iD, Piotr Szpak iD, Julita Kulbacka iD

Molecules · 12.06.2026 · 31 (12) · 2072

DOI: 10.3390/molecules31122072 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 12.06.2026. Verfasst von Wiktoria Andryszkiewicz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Wroclaw Medical University, Pasteura 1, 50-367 Wroclaw, Poland. Hauptthemen laut MEDLINE: Lipid Peroxidation, Oxidative Stress, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencja Badań Medycznych, Medical Research Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid peroxidation (LPO) is a process where polyunsaturated fatty acids (PUFA) in cellular membranes are oxidized. This process is mediated by reactive oxygen species (ROS) and leads to the formation of reactive products, including 4-hydroxynonenal (4-HNE), malondialdehyde (MDA), and oxidized phospholipids. At low concentrations these products act as second messengers in adaptive redox signalling and metabolic homeostasis, whereas at higher concentrations they compromise membrane integrity and promote cell death. Lipid peroxidation plays a crucial role in anticancer therapies. Here we focus on three mechanistically complementary drugs—sorafenib, cisplatin, and olaparib—because each converges, directly or indirectly, on the redox/LPO axis (system xc−/GPX4 modulation, mitochondrial ROS, and SLC7A11 regulation, respectively), modulating tumor cell responses by inducing PUFA oxidation, mitochondrial dysfunction, and membrane damage. However, tumor cells have several protective pathways against oxidative stress, such as increased expression of glutathione peroxidase 4 (GPX4), the SLC7A11 system Xc, and detoxification of reactive aldehydes. Enrichment of membranes with PUFA increases susceptibility to lipid peroxidation and ferroptosis, thereby sensitizing tumor cells to therapy, whereas enrichment with monounsaturated fatty acids (MUFA), driven by the SREBP1–SCD1 axis, limits peroxidation and confers resistance. Among regulated cell death modalities, ferroptosis is strictly dependent on lipid peroxidation, whereas apoptosis, necrosis, necroptosis, pyroptosis, and immunogenic cell death can be modulated by lipid peroxidation but do not universally require it. Collectively, these mechanisms indicate that lipid peroxidation is an important—though not exclusive—determinant of anticancer drug sensitivity and resistance, and that its dual, context-dependent role (tumor-suppressive at high flux, tumor-promoting under chronic, sub-lethal exposure) must be considered when designing LPO-based therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipid PeroxidationOxidative StressNeoplasmsAntineoplastic AgentsHumansCell DeathAnimalsReactive Oxygen SpeciesFerroptosisFatty Acids, Unsaturated

Stichwörter der Autor:innen

GPX4SLC7A11combination therapycuproptosisferroptosisimmunogenic cell deathlipid peroxidationreactive oxygen species

Substanzen

Antineoplastic AgentsReactive Oxygen SpeciesFatty Acids, Unsaturated

Autor:innen und Institutionen

  • Faculty of Medicine, Wroclaw Medical University, Pasteura 1, 50-367 Wroclaw, Poland.
  • University Hospital in Wroclaw (USK), Borowska 213, 50-556 Wroclaw, Poland.
  • Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, Poland.
  • Department of Immunology and Bioelectrochemistry, State Research Institute Centre for Innovative Medicine, LT-08406 Vilnius, Lithuania.

ORCID-Profile: Wiktoria Andryszkiewicz, Michał Filipski, Anna Wietrzyk, Piotr Szpak, Julita Kulbacka

Förderung

  • Agencja Badań Medycznych
  • Medical Research Agency

Zitieren

APA

Andryszkiewicz, W., Cichowska, Z., Filipski, M., Szyda, K., Wietrzyk, A., Szpak, P., & Kulbacka, J. (2026). Lipid Peroxidation in Cancer Therapy: Molecular Mechanisms Involving Oxidative Stress, Cell Death, and Therapeutic Response. Molecules, 31(12), 2072. https://doi.org/10.3390/molecules31122072

Vancouver

Andryszkiewicz W, Cichowska Z, Filipski M, Szyda K, Wietrzyk A, Szpak P, et al. Lipid Peroxidation in Cancer Therapy: Molecular Mechanisms Involving Oxidative Stress, Cell Death, and Therapeutic Response. Molecules. 2026;31(12):2072. doi:10.3390/molecules31122072

BibTeX
@article{Andryszkiewicz2026,
  author = {Andryszkiewicz, Wiktoria and Cichowska, Zuzanna and Filipski, Michał and Szyda, Kamila and Wietrzyk, Anna and Szpak, Piotr and Kulbacka, Julita},
  title = {Lipid Peroxidation in Cancer Therapy: Molecular Mechanisms Involving Oxidative Stress, Cell Death, and Therapeutic Response},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {12},
  pages = {2072},
  doi = {10.3390/molecules31122072}
}
Kostenlos starten →